SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001178913-17-000639
Filing Date
2017-02-24
Accepted
2017-02-24 16:05:19
Documents
7

Document Format Files

Seq Description Document Type Size
1 F-3 zk1719612.htm F-3 278116
2 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 38407
3 EXHIBIT 23.2 exhibit_23-2.htm EX-23.2 4979
4 image0.jpg GRAPHIC 78921
5 image00002.jpg GRAPHIC 2452
6 image00005.jpg GRAPHIC 6310
7 image00006.jpg GRAPHIC 5603
  Complete submission text file 0001178913-17-000639.txt   451526
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Filer) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-216224 | Film No.: 17637152
SIC: 2833 Medicinal Chemicals & Botanical Products